Sichenzia Ross Ference Carmel LLP Represents Sharps Technology, Inc. in $3.4 Million Reg A+ Warrant Inducement Offering

Press Release – New York, NY – June 17, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Sharps Technology, Inc. (NASDAQ: STSS), an innovative medical device and pharmaceutical company offering patented, best-in-class syringe products, in a $3.39 million Reg A+ warrant inducement offering. The offering combined a Reg A offering on Form 1-A and the exercise of existing warrants. 

The Sichenzia Ross Ference Carmel LLP team was led by partner Arthur Marcus and associate Jesse Blue.